Stock MLYS MINERALYS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Mineralys Therapeutics, Inc.

Equities

MLYS

US6031701013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
12.77 USD +2.82% Intraday chart for Mineralys Therapeutics, Inc. +4.67% +48.49%
May. 16 Transcript : Mineralys Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 05:01 PM
May. 09 Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Mineralys Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 05:01 PM
Mineralys Therapeutics : Corporate Overview May 2024
Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
Mineralys Therapeutics, Inc. Announces Alexander Asam Informs That His Decision Not to Stand for Re-Election to the Board
Goldman Sachs Initiates Mineralys Therapeutics at Buy With $30 Price Target
Mineralys Therapeutics Files Mixed-Securities Shelf Registration
Transcript : Mineralys Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Mineralys Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mineralys Therapeutics : Corporate Overview March 2024
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mineralys Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
North American Morning Briefing : Investors -2-
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
Sector Update: Health Care Stocks Ease in Late Afternoon
Sector Update: Health Care
Mineralys Therapeutics Secures $120 Million Financing Through Private Placement; Shares Rise
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MLYS Stock
  4. News Mineralys Therapeutics, Inc.
  5. Other languages